| abstract |
Disclosed is the use of milk fat enriched with c-9, t-l l conjugated linoleic acid (CLA) or a salt, ester or precursor thereof for treating or preventing a condition associated with one or more of leukocyte infiltration, eosinophilia, IgE secretion, airway remodelling, bronchoconstriction and mucus hypersecretion. |